<ARTICLE> 5 <MULTIPLIER> 1 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> JUN-30-1996 <CASH> 9,153,996 <SECURITIES> 12,026,858 <RECEIVABLES> 359,927 <ALLOWANCES> 0 <INVENTORY> 813,864 <CURRENT-ASSETS> 24,171,019 <PP&E> 8,074,866 <DEPRECIATION> 1,041,323 <TOTAL-ASSETS> 31,268,737 <CURRENT-LIABILITIES> 9,212,738 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 124,260 <OTHER-SE> 1,187,095 <TOTAL-LIABILITY-AND-EQUITY> 31,268,737 <SALES> 0 <TOTAL-REVENUES> 2,494,607 <CGS> 0 <TOTAL-COSTS> 7,356,202 <F1> <OTHER-EXPENSES> 0 <F1> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> (379,904) <INCOME-PRETAX> (5,995,746) <INCOME-TAX> 51,576 <INCOME-CONTINUING> (6,047,322) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (6,047,322) <EPS-PRIMARY> (0.53) <EPS-DILUTED> (0.53) <FN> <F1> Total costs includes research and development expenses and costs of revenues. Because of the nature of the company's operations, management is of the opinion that it is not meaningful to segregate these costs. </FN>